Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62018CA0524

    Case C-524/18: Judgment of the Court (Second Chamber) of 30 January 2020 (request for a preliminary ruling from the Bundesgerichtshof — Germany) — Dr. Willmar Schwabe GmbH & Co. KG v Queisser Pharma GmbH & Co. KG (Reference for a preliminary ruling — Public health — Information and consumer protection — Regulation (EC) No 1924/2006 — Implementing Decision 2013/63/EU — Nutritional and health claims made on foods — Article 10(3) — Reference to general, non-specific benefits — Concept of ‘accompanying’ a specific health claim — Obligation to produce scientific evidence — Scope)

    OJ C 137, 27.4.2020, p. 15–16 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    27.4.2020   

    EN

    Official Journal of the European Union

    C 137/15


    Judgment of the Court (Second Chamber) of 30 January 2020 (request for a preliminary ruling from the Bundesgerichtshof — Germany) — Dr. Willmar Schwabe GmbH & Co. KG v Queisser Pharma GmbH & Co. KG

    (Case C-524/18) (1)

    (Reference for a preliminary ruling - Public health - Information and consumer protection - Regulation (EC) No 1924/2006 - Implementing Decision 2013/63/EU - Nutritional and health claims made on foods - Article 10(3) - Reference to general, non-specific benefits - Concept of ‘accompanying’ a specific health claim - Obligation to produce scientific evidence - Scope)

    (2020/C 137/19)

    Language of the case: German

    Referring court

    Bundesgerichtshof

    Parties to the main proceedings

    Applicant: Dr. Willmar Schwabe GmbH & Co. KG

    Defendant: Queisser Pharma GmbH & Co. KG

    Operative part of the judgment

    1.

    Article 10(3) of Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods, as amended by Commission Regulation (EC) No 107/2008 of 15 January 2008 of the European Parliament and of the Council, must be interpreted as meaning that the requirement which it lays down that any reference to general, non-specific benefits of the nutrient or food must be accompanied by a specific health claim included in the lists provided for in Articles 13 or 14 of that regulation, is not satisfied where the packaging of a food supplement contains a reference to general, non-specific health benefits of a nutrient or food on the front of the packaging, whereas the specific health claim intended to accompany it appears only on the back of that packaging and there is no clear reference, such as an asterisk, between the two;

    2.

    Article 10(3) of Regulation No 1924/2006 as amended by Regulation No 107/2008 must be interpreted as meaning that references to general, non-specific benefits of a nutrient or food for overall good health or health-related well-being must be justified by scientific evidence within the meaning of Articles 5(1)(a) and 6(1) of that regulation. To that end, it suffices for such references to be accompanied by specific health claims included in the lists provided for in Article 13 or Article 14 of that regulation.


    (1)  OJ C 392, 29.10.2018.


    Top